Stockreport

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules [Yahoo! Finance]

Edgewise Therapeutics, Inc.  (EWTX) 
PDF disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions, today announced that on September 30, 2025 , Edg [Read more]